VA (congestive heart failure, hypertension, age ≥75 years (double weight), diabetes mellitus, previous stroke (double weight) ...
Objectives Elevated resting heart rate (RHR) predicts mortality in middle-aged and older adults, primarily through ...
Background The reported prevalence and burden of coronary artery disease in young adults varies markedly in published studies ...
Background Invasive procedures, including endomyocardial biopsy (EMB), right heart catheterisation (RHC) and coronary ...
Background C-reactive protein (CRP) is commonly used to assess systemic inflammation, yet its prognostic value in acute ...
Background Rheumatic heart disease (RHD) remains a major cause of morbidity and mortality in low-resource settings, ...
Objective Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy characterised by pathological left ...
This study aimed to explore whether baseline values and 12-month change in the 6-Minute Walk Distance (6MWD) and the physical ...
Original research: Operational performance of the 2023 World Heart Federation screening criteria for rheumatic heart disease in a high-risk, resource-limited population (8 July, 2026) ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for atrioventricular block (AVB) aiming to avoid ventricular dyssynchrony and adverse heart ...
Background Patients with angina and no obstructive coronary artery disease (ANOCA) frequently receive empirical antianginal therapy that fails to target underlying pathophysiological mechanisms.
Background Guidelines permit up to 360 J for synchronised biphasic electrical cardioversion (ECV) in atrial fibrillation (AF) lasting >48 hours. The CHESS randomised trial reported higher first-shock ...